Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Hunan Province Tumor Hospital
Fudan University
Eastern Cooperative Oncology Group
Helix BioPharma Corporation
Swiss Cancer Institute
Morphotek
Shanghai Chest Hospital
Swiss Cancer Institute
Swiss Cancer Institute
Swiss Cancer Institute
Shanghai Pulmonary Hospital, Shanghai, China
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Guangzhou Medical University
National Cancer Institute (NCI)
SWOG Cancer Research Network
SWOG Cancer Research Network
SWOG Cancer Research Network
Swiss Cancer Institute
National Cancer Institute (NCI)